Biotech major Amgen strikes deal for Onyx for $10.4bn

WASHINGTON – World’s biggest biotechnology company, Amgen has entered into a deal to acquire cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash to gain access to the company’s three anticancer treatments The acquisition, the fifth-largest biotechnology deal in history, ends a two-month-long battle for Onyx, with the per-share bid marking a 4.2% increase from the $120 it …

Powered by WPeMatico

This entry was posted in Nigeria News. Bookmark the permalink.

Leave a Reply